和元生物(688238.SH)：2025年预亏1.95亿元至2.37亿元

Core Viewpoint - The company, Heyuan Bio (688238.SH), expects to reduce its net loss for the year 2025, projecting a net profit attributable to shareholders of between -237 million to -195 million yuan, representing a reduction in loss of 84.81 million to 127 million yuan compared to the previous year, with a decrease in loss margin of 26.35% to 39.41% [1] Financial Projections - The company anticipates a net profit attributable to shareholders, excluding non-recurring gains and losses, to be between -244 million to -201 million yuan, which indicates a reduction in loss of 91.91 million to 135 million yuan compared to the previous year, with a decrease in loss margin of 27.36% to 40.16% [1]